Suppr超能文献

炭疽芽孢杆菌对人类抗菌肽LL-37的蛋白水解降解可能有助于其毒力。

Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.

作者信息

Thwaite Joanne E, Hibbs Stephen, Titball Richard W, Atkins Timothy P

机构信息

Biomedical Sciences, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom.

出版信息

Antimicrob Agents Chemother. 2006 Jul;50(7):2316-22. doi: 10.1128/AAC.01488-05.

Abstract

In this paper we report on the susceptibilities of a range of Bacillus species to the human antimicrobial peptide LL-37. B. subtilis showed a low level of resistance to killing by LL-37 (50% growth-inhibitory concentration [GI50], 1 microg/ml). B. cereus and B. thuringiensis showed intermediate levels of resistance to killing (GI50s, 33 microg/ml and 37 microg/ml, respectively). B. anthracis showed the highest level of resistance (GI50s, 40 to 66 microg/ml). The degradation of LL-37 by B. anthracis culture supernatant was blocked by the metalloprotease inhibitors EDTA and 1,10-phenanthroline, and the gene encoding the protease responsible for LL-37 degradation was not plasmid borne. Our findings suggest that alongside the classical plasmid-based virulence determinants, extracellular metalloproteases of B. anthracis may play a role in survival in the host.

摘要

在本文中,我们报告了一系列芽孢杆菌属物种对人类抗菌肽LL-37的敏感性。枯草芽孢杆菌对LL-37杀伤的抗性较低(50%生长抑制浓度[GI50],1微克/毫升)。蜡状芽孢杆菌和苏云金芽孢杆菌对杀伤的抗性处于中等水平(GI50分别为33微克/毫升和37微克/毫升)。炭疽芽孢杆菌表现出最高水平的抗性(GI50为40至66微克/毫升)。炭疽芽孢杆菌培养上清液对LL-37的降解被金属蛋白酶抑制剂乙二胺四乙酸(EDTA)和1,10-菲咯啉阻断,且编码负责LL-37降解的蛋白酶的基因不是质粒携带的。我们的研究结果表明,除了经典的基于质粒的毒力决定因素外,炭疽芽孢杆菌的细胞外金属蛋白酶可能在宿主生存中发挥作用。

相似文献

1
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.
Antimicrob Agents Chemother. 2006 Jul;50(7):2316-22. doi: 10.1128/AAC.01488-05.
2
ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.
J Innate Immun. 2009;1(5):494-506. doi: 10.1159/000225955. Epub 2009 Jun 18.
4
Cathelicidin peptide rescues G. mellonella infected with B. anthracis.
Virulence. 2018 Jan 1;9(1):287-293. doi: 10.1080/21505594.2017.1293227. Epub 2017 Mar 8.
6
Cathelicidin administration protects mice from Bacillus anthracis spore challenge.
J Immunol. 2008 Oct 1;181(7):4989-5000. doi: 10.4049/jimmunol.181.7.4989.
9
Bacillus anthracis protease InhA regulates BslA-mediated adhesion in human endothelial cells.
Cell Microbiol. 2012 Aug;14(8):1219-30. doi: 10.1111/j.1462-5822.2012.01791.x. Epub 2012 Apr 17.

引用本文的文献

1
Extracellular defense of bacteria against antimicrobial peptides.
J Bacteriol. 2025 Aug 21;207(8):e0016625. doi: 10.1128/jb.00166-25. Epub 2025 Aug 1.
2
The identity of implant materials governs the antimicrobial efficacy of SET-M33.
Sci Rep. 2025 May 10;15(1):16353. doi: 10.1038/s41598-025-99808-w.
4
Outer membrane vesicle contributes to the resistance to antimicrobial peptides in the acidic airway of bronchiectasis patients.
MedComm (2020). 2025 Jan 30;6(2):e70084. doi: 10.1002/mco2.70084. eCollection 2025 Feb.
5
Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.
Microorganisms. 2024 Jun 21;12(7):1259. doi: 10.3390/microorganisms12071259.
6
Understanding the Dynamics of Human Defensin Antimicrobial Peptides: Pathogen Resistance and Commensal Induction.
Appl Biochem Biotechnol. 2024 Oct;196(10):6993-7024. doi: 10.1007/s12010-024-04893-8. Epub 2024 Mar 13.
7
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides.
PLoS Pathog. 2022 Sep 29;18(9):e1010851. doi: 10.1371/journal.ppat.1010851. eCollection 2022 Sep.
8
Self-assembly of glycerol monooleate with the antimicrobial peptide LL-37: a molecular dynamics study.
RSC Adv. 2020 Feb 26;10(14):8291-8302. doi: 10.1039/c9ra10037g. eCollection 2020 Feb 24.
9
Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model.
Antibiotics (Basel). 2021 Oct 5;10(10):1210. doi: 10.3390/antibiotics10101210.
10
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.
Antibiotics (Basel). 2021 May 29;10(6):650. doi: 10.3390/antibiotics10060650.

本文引用的文献

1
Immunomodulatory activities of small host defense peptides.
Antimicrob Agents Chemother. 2005 May;49(5):1727-32. doi: 10.1128/AAC.49.5.1727-1732.2005.
2
Plasmid-encoded regulator of extracellular proteases in Bacillus anthracis.
J Bacteriol. 2005 May;187(9):3133-8. doi: 10.1128/JB.187.9.3133-3138.2005.
3
Effective antiprotease-antibiotic treatment of experimental anthrax.
BMC Infect Dis. 2005 Apr 8;5:25. doi: 10.1186/1471-2334-5-25.
4
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9. doi: 10.1128/AAC.48.12.4673-4679.2004.
5
Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.
Biochemistry. 2004 Jul 6;43(26):8459-69. doi: 10.1021/bi036284s.
7
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
N Engl J Med. 2002 Oct 10;347(15):1151-60. doi: 10.1056/NEJMoa021481.
8
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.
Mol Microbiol. 2002 Oct;46(1):157-68. doi: 10.1046/j.1365-2958.2002.03146.x.
9
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses.
J Immunol. 2002 Oct 1;169(7):3883-91. doi: 10.4049/jimmunol.169.7.3883.
10
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis.
Immunology. 2002 May;106(1):20-6. doi: 10.1046/j.1365-2567.2002.01398.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验